XML 68 R57.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2019
stock_awards
Feb. 28, 2018
stock_awards
Jun. 30, 2019
USD ($)
$ / shares
shares
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
tranch
$ / shares
shares
Jun. 30, 2018
USD ($)
shares
Dec. 31, 2018
$ / shares
shares
Stock-Based Compensation [Abstract]              
Number of types of stock-based awards granted (in types) | stock_awards 2 2          
Fair market value of awards | $         $ 11,400 $ 15,200  
Stock-based compensation expense | $     $ 1,869 $ 2,445 4,069 4,731  
Tax benefit from compensation expense | $         1,000 1,200  
Unrecognized compensation expense | $     10,900   $ 10,900    
Unrecognized compensation, period for recognition         1 year 10 months 24 days    
Performance Shares [Member]              
Stock-Based Compensation [Abstract]              
Stock-based compensation expense | $     $ 736 1,231 $ 1,715 $ 2,318  
Number of shares [Abstract]              
Outstanding, December 31, 2018 | shares         429,788    
Granted | shares         110,923 78,976  
Performance condition adjustment, net (a) | shares [1]         1,443    
Vested | shares         (223,706)    
Forfeited | shares         (19,545)    
Outstanding, June 30, 2019 | shares     298,903   298,903   429,788
Weighted Average Grant Date Fair Value [Abstract]              
Outstanding, December 31, 2018 | $ / shares         $ 25.90    
Granted | $ / shares         29.48    
Performance condition adjustment, net (a) | $ / shares [1]         43.05    
Vested | $ / shares         19.97    
Forfeited | $ / shares         35.97    
Outstanding, June 30, 2019 | $ / shares     $ 31.09   $ 31.09   $ 25.90
Restricted Stock Units (RSUs) [Member]              
Stock-Based Compensation [Abstract]              
Stock-based compensation expense | $     $ 1,133 $ 1,214 $ 2,354 $ 2,413  
Number of shares [Abstract]              
Outstanding, December 31, 2018 | shares         289,173    
Granted | shares         166,180 99,087  
Performance condition adjustment, net (a) | shares         0    
Vested | shares         (183,311)    
Forfeited | shares         (13,136)    
Outstanding, June 30, 2019 | shares     258,906   258,906   289,173
Weighted Average Grant Date Fair Value [Abstract]              
Outstanding, December 31, 2018 | $ / shares         $ 29.52    
Granted | $ / shares         29.06    
Performance condition adjustment, net (a) | $ / shares         0    
Vested | $ / shares         26.43    
Forfeited | $ / shares         35.34    
Outstanding, June 30, 2019 | $ / shares     $ 31.11   $ 31.11   $ 29.52
Officer [Member]              
Stock-Based Compensation [Abstract]              
Performance Shares that could be awarded, as a percentage of ROIC target amount, minimum         0.00%    
Performance Shares that could be awarded, as a percentage of ROIC target amount, maximum         200.00%    
Vesting period (in years)         3 years    
Performance Shares Target Percentage Earned, Officers             100.00%
Other employees [Member]              
Stock-Based Compensation [Abstract]              
Performance Shares that could be awarded, as a percentage of EBITDA target amount, minimum         0.00%    
Performance Shares that could be awarded, as a percentage of EBITDA target amount, maximum         200.00%    
Number of equal tranches for annual vesting (in tranches) | tranch         3    
Performance Shares Target Percentage Earned, Other Employees             110.00%
Officers and other employees [Member] | Restricted Stock Units (RSUs) [Member]              
Stock-Based Compensation [Abstract]              
Number of equal tranches for annual vesting (in tranches) | tranch         3    
Nonemployee Directors [Member] | Restricted Stock Units (RSUs) [Member]              
Stock-Based Compensation [Abstract]              
Vesting period (in years)         1 year    
[1] Represents additional PSUs granted to non-officers based on achievement of 2018 EBITDA in excess of target.